Henry Kissinger

FederalFederal Criminal TrialAug 31, 2021 – Jan 3, 2022

Henry Kissinger appeared principally in Daniel Mosley's testimony as the client who introduced Mosley to Theranos and asked him to assess Holmes and the company. The proceedings also connected Kissinger to introductions made through Mosley and to Roger Parloff's research for the Fortune profile.

Day 24

Oct 26, 2021

CrossLisa Peterson — CrossLisa PetersonLance A. WadeMentioned

Summary

Peterson acknowledged major limits on RDV's independent Theranos diligence while disputing that enthusiasm or informal emails replaced formal approval of the approximately $100 million investment.

Mentioned in this proceeding.

Day 26

Nov 2, 2021

ProceduralHearing on Daniel Mosley EvidenceMentioned

Summary

The court deferred a decision on using Daniel Mosley's 2015 emails during cross-examination and scheduled the motion concerning witness BB for the next morning.

Mentioned in this proceeding.

DirectDaniel Mosley — DirectDaniel MosleyJeff SchenkMentioned

Summary

Mosley described the Theranos materials, claimed outside validation, projections, and risk assumptions that led him to invest just under $6 million.

Mentioned in this proceeding.

CrossDaniel Mosley — CrossDaniel MosleyLance A. WadeMentioned

Summary

Mosley acknowledged using his investor network to facilitate Theranos introductions while the defense emphasized his sophistication, documentary access, and opportunity to seek clarification.

Mentioned in this proceeding.

Day 27

Nov 3, 2021

CrossDaniel Mosley — CrossDaniel MosleyLance A. WadeMentioned

Summary

Mosley described how Theranos materials, outside relationships, future plans, known risks, and negotiated investor protections shaped his preliminary analysis and investment decision.

Mentioned in this proceeding.

CrossDaniel Mosley — Cross (Resumed)Daniel MosleyLance A. WadeMentioned

Summary

Mosley described investor introductions, continuing diligence, outside validation, and rollout risk while defense counsel tested his regulatory recollection and documented the path to several proposed investments.

Mentioned in this proceeding.

CrossDaniel Mosley — Cross (Resumed)Daniel MosleyLance A. Wade2highlightsMentioned

Summary

Mosley confirmed facilitating introductions involving Holmes, including contacts requested by Henry Kissinger and a connection with his client Alice Walton.

Mentioned in this proceeding.

Highlights (2)

testimony highlightMosley said he believed he introduced Hank Slack and Mr. Ohana at Henry Kissinger's request, adding that he did not think he had met Slack and that Kissinger contacted John Elkann regarding Ohana.Open in transcript →

Quote“I THINK I DID PROVIDE AN INTRODUCTION AT THE REQUEST OF DR. KISSINGER.”— Daniel MosleyMosley directly attributed one of his Theranos-related introductions to Henry Kissinger's request.Open in transcript →

RedirectDaniel Mosley — RedirectDaniel MosleyJeff SchenkMentioned

Summary

Mosley said he understood several Theranos claims as current capabilities, not future vision, and denied encouraging the sophisticated clients he introduced to invest.

Mentioned in this proceeding.

Day 35

Nov 18, 2021

CrossRoger Parloff — Cross ResumedRoger ParloffJohn D. ClineMentioned

Summary

Parloff confirmed a broad set of sources and positive external information behind his reporting, acknowledged that a confidential laboratory was Quest, and denied that competitors supplied the criticisms he raised with Holmes.

Mentioned in this proceeding.

Day 36

Nov 19, 2021

CrossRoger Parloff — CrossRoger ParloffJohn D. ClineMentioned

Summary

Defense counsel tested whether Parloff remembered a direct military-use claim or only an inference, examined his article's tests-versus-CPT wording, and documented the breadth of his research through testimony and two admitted email exhibits.

Mentioned in this proceeding.

About

Trial Record (10)

Day 24

Summary

Day 26

Summary

Summary

Summary

Day 27

Summary

Summary

Summary

Highlights (2)

Summary

Day 35

Summary

Day 36

Summary